Beranda › Gangguan Depresi Mayor › Massachusetts
Uji klinis Gangguan Depresi Mayor di Massachusetts
45 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Watertown
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Watertown
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Adams Clinical LLC, Watertown
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Activmed Practices & Research, Llc - Methuen, Methuen
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Boston Childrens Hospital, Boston
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Boston, Boston
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Boston
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06830044The Medically Tailored Groceries and Mental Health Study
- UMass Chan Medical School, Worcester
- Community Care Cooperative (C3), Worcester
- UMass Memorial Health, Worcester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07779707Accelerated TMS for Perinatal Depression
- Brigham and Women's Hospital, Boston
Menerima peserta
Usia 18 hingga 55 · Wanita · Diperbarui 18 Sep 2026 · NCT06968390A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Boston
- Seaport Investigator Site, Russells Mills
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Adams Clinical, Inc., Watertown
- Vitalix Clinical, Inc., Worcester
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Adams Clinical Boston, Boston
- Activmed Practices & Research, Llc - Methuen, Methuen
- Adams Clinical Watertown, Watertown
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Boston
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Menerima peserta
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Watertown
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07300969Home-Based tDCS Treatment Of Major Depressive Disorder
- Curavit Clinical Research (virtual study site), Boston
Menerima peserta
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06976697The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown
Menerima pesertaFase 3
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06247839A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Boston
- Vitalix Clinical, Worcester
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Boston, Boston
- K2 Medical Research - Foxborough, Foxborough
- Adams Clinical Watertown, Watertown
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Boston Clinical Trials Llc, Boston
- ELIXIA, Springfield
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Mayflower Clinical, Russells Mills
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Vitalix Clinical, Worcester
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Boston
- Neurocrine Clinical Site, Watertown
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Springfield
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07484217Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Boston, Boston
- Adams Clinical, Watertown, Watertown
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05800925Neural Correlates of Stress and Perceived Control in Adolescent Depression
- McLean Hospital, Belmont
Menerima pesertaSukarelawan sehat diterima
Usia 14 hingga 18 · Wanita · Diperbarui 19 Mei 2026 · NCT04788524Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
- Mclean Hospital, Belmont
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT05232032Mechanisms Of Orbitofrontal Stimulation in Depression
- Beth Israel Deaconess Medical Center, Boston
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07230990Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
- McLean Hospital, Belmont
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT07560878A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Elixia MA, Springfield
- Adams Clinical, Watertown
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830Mindfulness-Based fMRI Neurofeedback for Depression
- Northeastern University, Boston
Menerima peserta
Usia 13 hingga 18 · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT05617495REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Lindus Health (Virtual Study Site), Boston
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT07280065Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- McLean Hospital, Belmont
- Beth Israel Deaconess Medical Center, Boston
Menerima pesertaStudi observasional
Usia 18 hingga 40 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06740383Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- Harvard Medical School, Boston
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #137, Boston
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06633016Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
- Massachusetts General Hospital, Boston
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 12 Des 2025 · NCT05450432Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06786624Stress Dynamics and Familial Risk for Depression in Female Adolescents
- McLean Hospital, Belmont
Menerima pesertaSukarelawan sehat diterima
Usia 13 hingga 15 · Wanita · Diperbarui 23 Okt 2025 · NCT06816329Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- McLean Hospital, Belmont
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 21 Okt 2025 · NCT05630963Targeting Specific Brain Networks to Treat Specific Symptoms in Depression
- Massachusetts General Hospital, Boston
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT05523817Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.